Samsung Biologics poised for growth pending BIOSECURE bill approval in US from BioPharma-Reporter.com
The bill, introduced in the House of Representatives in January 2024, aims to restrict federal government funding and partnerships with a few Chinese companies deemed a threat to national security. According to GlobalData, South Korean CDMO Samsung …